Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
10%
Ph phase_4
1
10%
Ph not_applicable
7
70%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 41 (11.1%)
N/A7 (77.8%)

Trials by Status

completed660%
unknown220%
recruiting220%

Recent Activity

2 active trials
Showing 5 of 10
recruitingnot_applicable

Association of Urine BDNF and NGF With Lower Urinary System Parameters

NCT06265519
recruitingnot_applicable

HoLEP vs BipolEP in Management of BPH Patients With Large Prostates

NCT06759194
unknownnot_applicable

Prospective Randomized Trial of Irritative Symptoms Severity Assessment After (HoLEP) Versus ThuFLEP

NCT04342533
completednot_applicable

HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH

NCT04935151
unknownnot_applicable

Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia

NCT04236687
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06265519Not Applicable

Association of Urine BDNF and NGF With Lower Urinary System Parameters

Recruiting
NCT06759194Not Applicable

HoLEP vs BipolEP in Management of BPH Patients With Large Prostates

Recruiting
NCT04342533Not Applicable

Prospective Randomized Trial of Irritative Symptoms Severity Assessment After (HoLEP) Versus ThuFLEP

Unknown
NCT04935151Not Applicable

HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH

Completed
NCT04236687Not Applicable

Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia

Unknown
NCT03460873

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Completed
NCT00877669Phase 2

Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH

Completed
NCT04143399Not Applicable

HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial

Completed
NCT03998150Not Applicable

Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study

Completed
NCT01810068Phase 4

Evaluation of the Effects of Different Prostate Surgeries on Urinary and Sexual Function

Completed

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10